Why India's Regulatory System is Different For companies entering India with Biological products for the first time, one of the most frequent surprises is the multiplicity of Regulatory authorities involved in approval,...

Why India Demands a Dedicated Biosimilar Strategy India is one of the fastest-growing Biosimilar markets in the world, driven by a large patient population, expanding government healthcare coverage under Ayushman Bharat, and...

The Regulatory Pathway for Biologicals in India is governed by strict guidelines to ensure the safety, efficacy, and quality of biological products. Manufacturers must follow regulatory frameworks established by CDSCO and the...